Collaborating for biologic breakthroughs, IBM and Boehringer Ingelheim merge genAI with foundation models. IBM’s cutting-edge AI expedites antibody discovery, targeting diseases like cancer, autoimmune disorders, and infections. Boehringer’s validation of refined antibodies affirms in-silico…
Continue Reading
German pharmaceutical company Boehringer Ingelheim and tech giant IBM are teaming up to harness the power of genAI and foundation models to further biologic drug discovery.The partnership leverages IBM’s foundation model technologies, consisting of…
Continue Reading
What You Should Know:
– Boehringer Ingelheim and IBM announced a collaboration to leverage IBM’s foundation model technologies for the discovery of novel candidate antibodies in drug development.
– The partnership will focus on utilizing IBM’s…
Continue Reading
NHSE’s procurement for the Federated Data Platform and award of a £330m contract is story that has stretched over more than three years, to the start of the Covid-19 pandemic, during which time Palantir has become…
Continue Reading
NHS England has awarded a contract to operate its future federated data platform project (FDP), worth £330 million, to US data analytics giant Palantir, with support from Accenture, PwC, NECS and Carnall Farrar, NHSE…
Continue Reading
US analytics and AI firm Palantir and Accenture have been chosen as the winner of the £480m Federated Data Platform procurement, with an announcement expected imminently.Palantir, the current supplier for FDP, and widely seen…
Continue Reading
With a new accelerator program offered by Cleveland Clinic, early- and growth-stage healthcare innovation companies could gain access to the massively powerful data and analytics insights promised by its new quantum computer, billed as…
Continue Reading
What You Should Know:
The Cleveland Clinic announced the launch of its Quantum Innovation Catalyzer Program, a competitive program designed for startup companies aiming to explore quantum computing applications in healthcare and life sciences.
– Cleveland…
Continue Reading
Cleveland Clinic and IBM have secured $40 million in funding from the Wellcome Trust to lead quantum computing projects for healthcare applications. The initiative, part of the Wellcome Leap Quantum for Bio Challenge, aims…
Continue Reading
The Wellcome Trust has selected the Cleveland Clinic-IBM Discovery Accelerator to develop proof-of-concept demonstrations of quantum computing for biologic and health applications through the Wellcome Leap Quantum for Bio Challenge.WHY IT MATTERS
Q4Bio by Wellcome…
